- Home
- GAN vs CLRB Comparison
GAN vs CLRB Comparison
Compare GAN & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAN
- CLRB
- Stock Information
- Founded
- GAN 1999
- CLRB 2002
- Country
- GAN United States
- CLRB United States
- Employees
- GAN N/A
- CLRB N/A
- Industry
- GAN Computer Software: Programming Data Processing
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- GAN Technology
- CLRB Health Care
- Exchange
- GAN Nasdaq
- CLRB Nasdaq
- Market Cap
- GAN 79.1M
- CLRB 76.0M
- IPO Year
- GAN 2020
- CLRB N/A
- Fundamental
- Price
- GAN $1.80
- CLRB $2.04
- Analyst Decision
- GAN
- CLRB Strong Buy
- Analyst Count
- GAN 0
- CLRB 2
- Target Price
- GAN N/A
- CLRB $21.00
- AVG Volume (30 Days)
- GAN 171.5K
- CLRB 237.5K
- Earning Date
- GAN 11-08-2024
- CLRB 11-18-2024
- Dividend Yield
- GAN N/A
- CLRB N/A
- EPS Growth
- GAN N/A
- CLRB N/A
- EPS
- GAN N/A
- CLRB N/A
- Revenue
- GAN $134,024,000.00
- CLRB N/A
- Revenue This Year
- GAN $5.97
- CLRB N/A
- Revenue Next Year
- GAN $11.32
- CLRB N/A
- P/E Ratio
- GAN N/A
- CLRB N/A
- Revenue Growth
- GAN N/A
- CLRB N/A
- 52 Week Low
- GAN $1.17
- CLRB $1.82
- 52 Week High
- GAN $1.85
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- GAN 49.51
- CLRB 50.95
- Support Level
- GAN $1.77
- CLRB $2.06
- Resistance Level
- GAN $1.84
- CLRB $2.18
- Average True Range (ATR)
- GAN 0.03
- CLRB 0.08
- MACD
- GAN -0.00
- CLRB 0.01
- Stochastic Oscillator
- GAN 42.86
- CLRB 52.17
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.